SpyGlass Pharma (NAS: SGP)

Surgical Devices · Aliso Viejo, CA · Founded 2019 · Publicly Held

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug… SpyGlass Pharma (NAS: SGP) is based in Aliso Viejo, CA and was founded in 2019. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $511 million (Feb 2026). It has raised $349 million across 2 recorded rounds; the latest was a $75 million Series D in Jun 2025.

Last price · $/share
—
Implied valuation
$510.6M
Total raised
$348.5M
Last round
Later Stage VC (Series D)
Jun 2025
What is SpyGlass Pharma (NAS: SGP) worth?
$510.6Mlast known valuation

SpyGlass Pharma (NAS: SGP) last raised $75.0M in its Later Stage VC (Series D) (Jun 2025).

Free account
More of SpyGlass Pharma (NAS: SGP) with a free account
  • ·Watch SpyGlass Pharma (NAS: SGP): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

SpyGlass Pharma (NAS: SGP) funding history

2 rounds
DateRoundRaisedPost-money
Jun 2025Later Stage VC (Series D)$75.0M▮
Jul 2023Later Stage VC (Series C)$90.0M▮
Unlock post-money valuations

Membership and data by Private Market View

SpyGlass Pharma (NAS: SGP) valuation

SpyGlass Pharma (NAS: SGP) is now publicly traded; this page covers its private-market history, where its last recorded valuation was $511 million (Feb 2026). Secondary trades, fund marks and rounds below are the private-market record; the listed share price is not tracked here.

How much has SpyGlass Pharma (NAS: SGP) raised?

SpyGlass Pharma (NAS: SGP) has raised $349 million in total; 2 of its rounds are on record. The largest on record was a $90 million Series C in Jul 2023; the most recent was a $75 million Series D in Jun 2025.

Comparable companies

Comparable surgical devices names by valuation on PrivateMarketView: Imperative Care ($1.6 billion), Eximis Surgical ($18.7 million) and FEMSelect ($17 million).

How SpyGlass Pharma (NAS: SGP)'s valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For SpyGlass Pharma (NAS: SGP), too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about SpyGlass Pharma (NAS: SGP)

What is SpyGlass Pharma (NAS: SGP) worth?
SpyGlass Pharma (NAS: SGP)'s last known valuation is $510.6M.
How much has SpyGlass Pharma (NAS: SGP) raised?
SpyGlass Pharma (NAS: SGP) has raised $348.5M in total funding across 2 recorded rounds.
When did SpyGlass Pharma (NAS: SGP) last raise?
SpyGlass Pharma (NAS: SGP) last raised in Jun 2025 (Later Stage VC (Series D)), raising $75.0M.